Stryker Corporation
SYK Healthcare Medical Devices
Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.42%, EPS grew 43.1%, free cash flow grew 14.1% and total debt fell 9.88%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.
Follow SYK
Stryker Corporation 10-K filed Feb 11, 2026
What changed
Item 7, Management’s Discussion and Analysis, against the 10-K filed Feb 12, 2025: 708 added · 84 removed · 11 modified; 10 with only figures updated; 7 moved without change
803 more changes in this Item, word by word, in Powerpack.
Powerpack